[Heres what you need to know about Pfizers Covid-19 Vaccine.]
On Nov. 17-18, DealBook is holding our first Online Summit. Join us as we welcome the most consequential newsmakers in business, policy and culture to explore the pivotal questions of the moment and the future. Watch for free from anywhere in the world. Register now.
The pandemic is still raging, but it would be hard to tell from the ecstatic stock market, which flirted with record highs thanks to promising clinical trial data on a coronavirus vaccine from Pfizer and BioNTech. Futures today suggest that yesterdays rally could be extended.
Hopes that the pandemic will come under control scrambled the usual pattern, with shares soaring for the sectors most linked to growth in the broad economy, like energy and banks, and the companies most affected by lockdowns, like AMC (up 51 percent), United Airlines (up 19 percent) and Macys (up 17 percent). Tech-heavy stars of the pandemic were the days biggest losers, like Peloton (down 20 percent), Zoom (down 17 percent) and Netflix (down 9 percent).
The probability of an L-shaped recovery has been significantly reduced, said Johanna Kyrklund, Schroders chief investment officer. We may finally have found the catalyst to spark a move away from the stay-at-home stocks that have benefited from lockdown, towards recovery stocks.
There are reasons to be wary. Experts cautioned that even if Pfizer wins approval for its vaccine and itll need much more data doses will be initially available to only a small sliver of the population. As our colleagues at The Morning newsletter note, there are two very different coronavirus stories happening now: While the markets are rejoicing, records for coronavirus infections are being set daily.
The key question: Are investors getting ahead of themselves? These are the types of moves that tend to run out of gas if the underlying data doesnt quickly confirm the enthusiasm, Lisa Shalett, chief investment officer at Morgan Stanley Wealth Management, told The Times. The sharp turns call into question the efficiency of supposedly all-knowing markets, as the Deal Professor notes below.
Europe charges Amazon with antitrust violations. The E.U.s competition chief, Margrethe Vestager, accused the e-commerce giant of exploiting data it collects from third-party merchants to boost its own sales. We must ensure that dual-role platforms with market power, such as Amazon, do not distort competition, she said.
Most Republicans back President Trumps refusal to concede. Officials like Senator Mitch McConnell, the majority leader, declined to rebut Mr. Trumps false claims of illegal votes and a stolen election. Separately, lawyers at Jones Day and Porter Wright, two big law firms working on Mr. Trumps legal challenges, have voiced concerns about their work.
Top SoftBank executives resign as directors. Three senior managers including Rajeev Misra, the head of the Vision Fund, and Marcelo Claure, the companys C.O.O. are stepping down from the board, amid pressure to improve SoftBanks corporate governance. (Theyll stay as executives.)
The E.U. imposes new tariffs on American goods. The $4 billion in levies, on products like aircraft and chocolate, follow a W.T.O. ruling allowing the bloc to retaliate against the U.S. over illegal subsidies to Boeing. The U.S. imposed tariffs on European goods last year after a similar ruling about Airbus.
Bill Grosss property fight with his neighbor heads to court. A trial over competing harassment claims by the famed bond investor and the entrepreneur Mark Towfiq began yesterday. Mr. Gross reportedly said he would stop blaring the Gilligans Island theme song if the neighbor dropped his complaint; a lawyer for Mr. Gross accused Mr. Towfiq of being a peeping Tom.
Steven Davidoff Solomon, a.k.a. the Deal Professor, is a professor at the U.C. Berkeley School of Law and the faculty co-director at the Berkeley Center for Law, Business and the Economy.
Recent weeks havent been good for the efficient markets hypothesis. First, the pollsters got the election wrong, failing to forecast the results for many of last weeks contests. Then, yesterday, investors got the markets wrong.
The burst upward in stocks was aided by the thesis that the calmness of a post-Trump era and divided government would be a boon to business. But make no mistake: Most of the rise was related to Pfizers vaccine news.
Whats so surprising about the rise is that it shouldnt have happened. This vaccine announcement was completely expected. Pfizer and other companies developing vaccines have been signaling a November announcement for weeks. And, in fact, some market observers have been factoring this into their advice on positioning.
Marko Kolanovic, the head of macro quantitative and derivatives strategy at JPMorgan Chase, has been right all year. He called the market bottom, then called the Nasdaq high as well as the turn to consumer cyclicals. He also put out a series of reports leading up to the election noting that evidence beyond the polls suggested President Trump would do better than expected.
Mr. Kolanovics forecasts show what were missing, despite being able to access more information than ever. People are driven by fear, live in the moment and get distracted by a deluge of extreme views on social media. This has been compounded by political bias which infects everything, including assessments of the markets. Trading is consumed by momentum plays and the Robinhood crowd. People have too much information and take longer to process meaningful signals.
All of this is to say that markets may still be efficient in the long term, but these days it takes even longer for this to become clear.
Rich Handler, the C.E.O. of Jefferies, in 20 Things I Wish Someone Told Me The Day I Started My Career As An Analyst On Wall Street
The Affordable Care Act is up for debate at the Supreme Court today. If the law is invalidated, some investors have prepared for refunds on past investment income. Indeed, the litigation has generated a flurry of queries and I.R.S. protective refund claims, tax experts say.
Todays arguments are about Obamacares individual mandate, a penalty for not taking out health insurance. Challengers say that when Congress set the penalty at zero in 2017, they broke the justification given for the entire law in a previous Supreme Court ruling, which depended on treating the mandate as a tax. Theoretically, if Texas and other Republican-leaning states backed by the federal government succeed in striking down the law, refunds could be available on other taxes associated with the A.C.A.
The I.R.S. cited the case in guidance on protective refund claims earlier this year. These claims are placeholders, reserving the right to file after deadline, depending on a future event like litigation. Some filers hope that other taxes will be invalidated if the A.C.A. is struck down, including a 3.8 percent hike on net income investment passed in a 2010 companion law.
Its a long shot. Even if the individual mandate falls, the court may preserve the health care law, and even the whole law falling wouldnt guarantee some of these refunds. Because arguments for unconstitutionality of the mandate depend on a change in law that was enacted in 2017 and did not take effect until 2019, it seems very unlikely that the court will hold that the A.C.A. was invalid as far back as 2016, Jonathan Gifford, a tax attorney at Cleary Gottlieb, told DealBook. But people filing protective refund claims presumably are thinking that anything can happen, and in 2020 that certainly seems truer than ever.
The Timess Brooks Barnes writes from Los Angeles: Months after his blink-and-you-missed it tenure as TikToks C.E.O., Kevin Mayer has taken on a new role: senior adviser to Len Blavatniks Access Industries.
He will bring invaluable knowledge and insight to Access, which owns media businesses like Warner Music and the sports streaming service DAZN, Mr. Blavatnik said. Before joining TikTok, Mr. Mayer led Disney+ and had been a contender to succeed Bob Iger as Disneys C.E.O. President Trumps pressure on TikToks Chinese owners curtailed the networks global ambitions, prompting Mr. Mayer to leave after just three months.
Mr. Mayer called the Access role a key component of my future endeavors. He has also held talks to join Redbird Capital, the sports and entertainment investment firm that recently launched a SPAC.
Travel is down, but when it returns it will be a little easier to get to the airport, a meeting or anywhere else at a set time. Later today, Uber will announce a feature that the business community has long wanted: reservations.
How it works. Through Uber Reserve, riders can schedule trips up to 30 days in advance in more than 20 U.S. cities. The program, which launches next week, will present its fare upfront, as usual. If a pickup doesnt arrive on time, riders get a $50 credit.
Its a swipe at legacy car services. The new program challenges the biggest advantage that car and limo services had over on-demand ride-hailing. But it may take some time to see any impact, given how little people are moving around these days.
Deals
NextEra Energy reportedly offered to buy a rival power utility, Evergy, for $15 billion in stock, months after being rebuffed by Duke Energy. (Reuters)
VF Corporation, which owns Vans and Timberland, will buy the buzzy streetwear brand Supreme for $2.1 billion. (NYT)
Politics and policy
Renewing the Feds emergency loan programs, which are set to expire at the end of the year, has become a bitter political fight. (NYT)
Britain will require big companies to report on climate risks. (Guardian)
Tech
President-elect Joe Biden is expected to continue the Justice Departments antitrust lawsuit against Google and may file competition cases against Facebook, Amazon and Apple. (NYT)
Zoom agreed to third-party audits of its security protocols as part of a proposed settlement with the Federal Trade Commission. (Protocol)
Best of the rest
Since President Trump took office, corporate America has been thrust into the culture wars like never before. (NYT)
Four Seasons the landscaping company, not the hotel is capitalizing on its unexpected role in the Trump campaigns legal challenges, selling shirts with slogans like Lawn and Order! (NYT)
Wed like your feedback! Please email thoughts and suggestions to dealbook@nytimes.com.
Read more here:
Are Markets Overexcited About Pfizer's Covid-19 Vaccine News? - The New York Times
- Covid-19 diagnostic based on MIT technology might be tested on patient samples soon - The MIT Tech [Last Updated On: March 16th, 2020] [Originally Added On: March 16th, 2020]
- Dutch researchers first to find Covid-19 antibodies: Report - NL Times [Last Updated On: March 16th, 2020] [Originally Added On: March 16th, 2020]
- Getting Viral: Why COVID-19 is Such a Threat to the 60+ Plus Population and Why the Response May Make It Worse - CounterPunch [Last Updated On: March 16th, 2020] [Originally Added On: March 16th, 2020]
- U.K. Scientists Paying People $4,000 to Get Infected with Coronaviruses - Newsweek [Last Updated On: March 16th, 2020] [Originally Added On: March 16th, 2020]
- Youre Likely to Get the Coronavirus - The Atlantic [Last Updated On: March 16th, 2020] [Originally Added On: March 16th, 2020]
- Mountain West Scientists Contributing To The Race For A COVID-19 Vaccine - KUNC [Last Updated On: March 16th, 2020] [Originally Added On: March 16th, 2020]
- China Threatens to Withhold COVID-19 Vaccine - The - The Floridian [Last Updated On: March 16th, 2020] [Originally Added On: March 16th, 2020]
- Look for novel coronavirus treatments first, experts say, and vaccines are further off than you think - FiercePharma [Last Updated On: March 16th, 2020] [Originally Added On: March 16th, 2020]
- COVID-19 vaccine will take at least two years to develop: health officials - The Hindu [Last Updated On: March 16th, 2020] [Originally Added On: March 16th, 2020]
- 'Where's the money?' Inside GeoVax, one lab working to create a COVID-19 vaccine - wgxa.tv [Last Updated On: March 16th, 2020] [Originally Added On: March 16th, 2020]
- Homeland Security News Wire: COVID-19 Virus Isolated Better Testing, Treatments, Vaccines Are Near - Los Alamos Daily Post [Last Updated On: March 16th, 2020] [Originally Added On: March 16th, 2020]
- With the coronavirus, drug that once raised global hopes gets another shot - STAT [Last Updated On: March 16th, 2020] [Originally Added On: March 16th, 2020]
- Farmington biotech teams with Yale to pursue COVID-19 vaccine - Hartford Business [Last Updated On: March 16th, 2020] [Originally Added On: March 16th, 2020]
- Father and daughter virologists working on vaccine for COVID-19 - National Observer [Last Updated On: March 16th, 2020] [Originally Added On: March 16th, 2020]
- Sanofi exploring possibility of COVID-19 vaccine that would be produced in Pa. - Bucks County Courier Times [Last Updated On: March 16th, 2020] [Originally Added On: March 16th, 2020]
- EMA offers free advice to COVID-19 vaccine and therapeutic developers - European Pharmaceutical Review [Last Updated On: March 16th, 2020] [Originally Added On: March 16th, 2020]
- Italy COVID-19 total tops 10000; funding grows for treatments, vaccines - CIDRAP [Last Updated On: March 16th, 2020] [Originally Added On: March 16th, 2020]
- Free Tests, Free Vaccines: Remove the Wealth Barriers to Fighting COVID-19 - The Nation [Last Updated On: March 16th, 2020] [Originally Added On: March 16th, 2020]
- Inovio Pharm gets $5M from Gates Foundation to further COVID-19 vaccine project - The San Diego Union-Tribune [Last Updated On: March 16th, 2020] [Originally Added On: March 16th, 2020]
- On the hunt for a Covid-19 vaccine - Vantage [Last Updated On: March 16th, 2020] [Originally Added On: March 16th, 2020]
- When will a coronavirus vaccine be ready? - The Guardian [Last Updated On: March 16th, 2020] [Originally Added On: March 16th, 2020]
- Coronavirus vaccine: why will it take so long to create? - Los Angeles Times [Last Updated On: March 16th, 2020] [Originally Added On: March 16th, 2020]
- Covid-19 vaccine in development by J&J and BIDMC. - Pharmaceutical Technology [Last Updated On: March 16th, 2020] [Originally Added On: March 16th, 2020]
- First COVID-19 vaccine trial starts Monday in Seattle, government official says - KOMO News [Last Updated On: March 16th, 2020] [Originally Added On: March 16th, 2020]
- Others at Kansas home tied to COVID-19 death tested negative - hays Post [Last Updated On: March 17th, 2020] [Originally Added On: March 17th, 2020]
- Commentary: Is the UK's herd immunity strategy to combat COVID-19 worth pursuing? - CNA [Last Updated On: March 17th, 2020] [Originally Added On: March 17th, 2020]
- 5 Promising Covid-19 Vaccines and Drugs That Could End Coronavirus Pandemic - Observer [Last Updated On: March 17th, 2020] [Originally Added On: March 17th, 2020]
- First human trial of COVID-19 vaccine gets under way in the US - EWN [Last Updated On: March 17th, 2020] [Originally Added On: March 17th, 2020]
- Government official: First dose to be delivered Monday in clinical trial for potential COVID-19 vaccine - Associated Press [Last Updated On: March 17th, 2020] [Originally Added On: March 17th, 2020]
- First stage of COVID-19 vaccine testing gets under way - The Mercury News [Last Updated On: March 17th, 2020] [Originally Added On: March 17th, 2020]
- The Race Is On To Find A Vaccine For COVID-19 - WCCO | CBS Minnesota [Last Updated On: March 17th, 2020] [Originally Added On: March 17th, 2020]
- 10 Positive Updates on the COVID-19 Outbreaks From Around the World - Good News Network [Last Updated On: March 17th, 2020] [Originally Added On: March 17th, 2020]
- Authorities warn of scam callers seeking sensitive information to reserve a vaccine for COVID-19 - FOX 13 Tampa Bay [Last Updated On: March 17th, 2020] [Originally Added On: March 17th, 2020]
- COVID-19 Vaccine Still on Phase 1 and Might Take 18 Months From Now to Create Says Global Health Official - Tech Times [Last Updated On: March 17th, 2020] [Originally Added On: March 17th, 2020]
- Army command continues work on COVID-19 vaccine, treatment | Hospital near Fort Detrick to setup drive-through testing site - WUSA9.com [Last Updated On: March 17th, 2020] [Originally Added On: March 17th, 2020]
- Australian researchers have made an important discovery in the race to find a COVID-19 vaccine - SBS News [Last Updated On: March 17th, 2020] [Originally Added On: March 17th, 2020]
- Regeneron aims to have coronavirus antibody treatment ready for human testing by early summer - CNBC [Last Updated On: March 17th, 2020] [Originally Added On: March 17th, 2020]
- Covid-19 outbreak: the key to quicker vaccine development - Pharmaceutical Technology [Last Updated On: March 17th, 2020] [Originally Added On: March 17th, 2020]
- COVID-19 Vaccine Test Begins With U.S. Volunteer | Time [Last Updated On: March 17th, 2020] [Originally Added On: March 17th, 2020]
- The FDA Regulatory Landscape for Covid-19 Treatments and Vaccines - JD Supra [Last Updated On: March 18th, 2020] [Originally Added On: March 18th, 2020]
- Montgomery Co. life science companies work together on COVID-19 vaccine - WDVM 25 [Last Updated On: March 18th, 2020] [Originally Added On: March 18th, 2020]
- Meet the volunteers testing the new experimental COVID-19 vaccine - CTV News [Last Updated On: March 18th, 2020] [Originally Added On: March 18th, 2020]
- The U.S. Should Make COVID-19 Testing, Prevention And Care Free To All - WBUR [Last Updated On: March 18th, 2020] [Originally Added On: March 18th, 2020]
- Biotech That Doubled on Covid-19 Frenzy Readies New Flu Vaccine - Bloomberg [Last Updated On: March 18th, 2020] [Originally Added On: March 18th, 2020]
- Jones sponsors bill for insurance plans to cover COVID-19 vaccines when they're available - alreporter.com [Last Updated On: March 18th, 2020] [Originally Added On: March 18th, 2020]
- Seattle volunteers receive world's first experimental COVID-19 vaccine - KOMO News [Last Updated On: March 18th, 2020] [Originally Added On: March 18th, 2020]
- What scientists are working on to find a cure for coronavirus COVID-19 - ABC News [Last Updated On: March 21st, 2020] [Originally Added On: March 21st, 2020]
- This study shows how difficult it will be to find Covid-19 vaccine volunteers - Ladders [Last Updated On: March 21st, 2020] [Originally Added On: March 21st, 2020]
- Differences between COVID-19 and flu? We have no immunity or vaccine for the new virus, local expert says - WFTV Orlando [Last Updated On: March 21st, 2020] [Originally Added On: March 21st, 2020]
- GeekWire Podcast: Bill Gates on COVID-19, gig workers in peril, and more on the coronavirus crisis - GeekWire [Last Updated On: March 21st, 2020] [Originally Added On: March 21st, 2020]
- Coronavirus vaccine: Expert warns that a usable Covid-19 vaccination won't be available for at least a year - inews [Last Updated On: March 21st, 2020] [Originally Added On: March 21st, 2020]
- COVID-19 Is Deadlier Than The Flu. How Else Do They Differ? : Goats and Soda - NPR [Last Updated On: March 21st, 2020] [Originally Added On: March 21st, 2020]
- Is This 'Good News' List About the COVID-19 Pandemic Accurate? - Snopes.com [Last Updated On: March 21st, 2020] [Originally Added On: March 21st, 2020]
- WHO expert: Finding and distributing COVID-19 vaccine in 18 months would be 'historic' - EURACTIV [Last Updated On: March 21st, 2020] [Originally Added On: March 21st, 2020]
- COVID-19: 5 reasons to be cautiously hopeful - Medical News Today [Last Updated On: March 21st, 2020] [Originally Added On: March 21st, 2020]
- Scammers are trying to trick people into reserving a COVID-19 vaccine over the phone - The Verge [Last Updated On: March 21st, 2020] [Originally Added On: March 21st, 2020]
- Coronavirus: How scientists are racing to find a Covid-19 vaccine - ITV News [Last Updated On: March 21st, 2020] [Originally Added On: March 21st, 2020]
- COVID-19 Vaccines Are Coming, but Theyre Not What You Think - The Atlantic [Last Updated On: March 21st, 2020] [Originally Added On: March 21st, 2020]
- First patients injected with potential COVID-19 vaccine in ... [Last Updated On: March 21st, 2020] [Originally Added On: March 21st, 2020]
- COVID-19 vaccine - Wikipedia [Last Updated On: March 21st, 2020] [Originally Added On: March 21st, 2020]
- Researchers working to fast-track a COVID-19 vaccine - FOX 9 [Last Updated On: March 23rd, 2020] [Originally Added On: March 23rd, 2020]
- Projects awarded 10.5m to boost Covid-19 vaccine research - National Health Executive [Last Updated On: March 23rd, 2020] [Originally Added On: March 23rd, 2020]
- CureVac denies reports that Trump admin sought to acquire Covid-19 vaccine rights - MedCity News [Last Updated On: March 23rd, 2020] [Originally Added On: March 23rd, 2020]
- Cork workers to be involved in race to find vaccine for Covid-19 - Echo Live [Last Updated On: March 23rd, 2020] [Originally Added On: March 23rd, 2020]
- COVID-19 Drugs And Vaccines Showing Promise - WVXU [Last Updated On: March 23rd, 2020] [Originally Added On: March 23rd, 2020]
- Moderna could make experimental COVID-19 vaccine available to healthcare workers by fall - TechCrunch [Last Updated On: March 23rd, 2020] [Originally Added On: March 23rd, 2020]
- Beware of Fraudulent Coronavirus Tests, Vaccines and Treatments - WBIW.com [Last Updated On: March 25th, 2020] [Originally Added On: March 25th, 2020]
- Singapore scientists plan to start testing COVID-19 vaccine this year: Gan Kim Yong - CNA [Last Updated On: March 25th, 2020] [Originally Added On: March 25th, 2020]
- Meet the scientists contributing to race for COVID-19 vaccine - Study International News [Last Updated On: March 25th, 2020] [Originally Added On: March 25th, 2020]
- The Covid-19 Vaccine: How Much Will It Cost & Who Will Have Access? - KALW [Last Updated On: March 25th, 2020] [Originally Added On: March 25th, 2020]
- Scientists race to find COVID-19 vaccine, as global cases of infection climb - Yahoo Finance [Last Updated On: March 25th, 2020] [Originally Added On: March 25th, 2020]
- Dynavax and Clover Biopharmaceuticals Announce Research Collaboration to Evaluate Coronavirus (COVID-19) Vaccine Candidate with CpG 1018 Adjuvant -... [Last Updated On: March 25th, 2020] [Originally Added On: March 25th, 2020]
- Soligenix Inc. Heat-Stabilization Platform Evaluating Use With COVID-19 Vaccine; Zacks Small-Cap Research Increases Valuation To $12.00 Per Share -... [Last Updated On: March 25th, 2020] [Originally Added On: March 25th, 2020]
- Inovio Pharmaceuticals Gets Help From Ology Bioservices and the Defense Department with Its COVID-19 Vaccine Candidate - The Motley Fool [Last Updated On: March 25th, 2020] [Originally Added On: March 25th, 2020]
- New coronavirus research suggests vaccines developed to treat it could be long-lasting - TechCrunch [Last Updated On: March 25th, 2020] [Originally Added On: March 25th, 2020]
- Hoth Surges on Collaboration With Voltron for COVID-19 Vaccine - Yahoo Finance [Last Updated On: March 25th, 2020] [Originally Added On: March 25th, 2020]
- UVM Researcher Offers Insights on Vaccines and COVID-19 - Seven Days [Last Updated On: March 27th, 2020] [Originally Added On: March 27th, 2020]
- 20 Indian institutes working to find Covid-19 vaccine, IITs focused on portable ventilators - ThePrint [Last Updated On: March 27th, 2020] [Originally Added On: March 27th, 2020]
- Researchers in Pittsburgh, Paris and Vienna Win Grant for COVID-19 Vaccine - UPJ Athletics [Last Updated On: March 27th, 2020] [Originally Added On: March 27th, 2020]
- Research Team in Race to Develop COVID-19 Vaccine and Treatments - USC Viterbi School of Engineering [Last Updated On: March 27th, 2020] [Originally Added On: March 27th, 2020]